EULALIA DIBATTISTE
Allopathic & Osteopathic Physicians|Family Medicine LANOKA HARBOR, NJ NPI 1104856434
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine NJ Novo Nordisk AS All categories
General Payments — all program years on this page
$623.70
- Category: General Payments
- Program years: PY2018–2019
- Record count: 45
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $128.30 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $128.30 | 9 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $88.48 | 6 |
| Amarin Pharma Inc. | $28.19 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $11.63 | 1 |
By program year
Records — PY2019 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 668743605 | Novo Nordisk Inc | $15.34 | 02/06/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 669486381 | Novo Nordisk Inc | $13.95 | 03/20/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 669486383 | Novo Nordisk Inc | $10.57 | 03/05/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 681884945 | Takeda Pharmaceuticals U.S.A., Inc. | $11.63 | 01/30/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 682512989 | Novo Nordisk Inc | $1.50 | 02/05/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 682512995 | Novo Nordisk Inc | $9.07 | 03/28/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 699055947 | Amarin Pharma Inc. | $13.50 | 01/08/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 699122103 | Amarin Pharma Inc. | $14.69 | 04/02/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 703514555 | Novo Nordisk Inc | $38.05 | 04/10/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.